PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | Defactinib | C20H21F3N8O3S

Defactinib

  • Molecular FormulaC20H21F3N8O3S
  • Average mass510.493 Da
  • Monoisotopic mass510.140930 Da
  • ChemSpider ID32695161

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1073154-85-4 [RN]
53O87HA2QU
9928
Benzamide, N-methyl-4-[[4-[[[3-[methyl(methylsulfonyl)amino]-2-pyrazinyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]- [ACD/Index Name]
defactinib [Spanish] [INN]
Defactinib [INN] [USAN]
défactinib [French] [INN]
defactinibum [Latin] [INN]
N-Methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]-2-pyrazinyl}methyl)amino]-5-(trifluormethyl)-2-pyrimidinyl}amino)benzamid [German] [ACD/IUPAC Name]
N-Methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]-2-pyrazinyl}methyl)amino]-5-(trifluoromethyl)-2-pyrimidinyl}amino)benzamide [ACD/IUPAC Name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

PubChem Substance ID 329825761 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      5 Axon Medchem 2574
      H303;H313;H317;H333;H334;H335;H383 Axon Medchem 2574
      no pictogram Axon Medchem 2574
      P101;P102;P103;P260;P262;P263;P264;P270;P280;P304;P312;P350 Axon Medchem 2574
      Warning Axon Medchem 2574
    • Target Organs:

      FAK inhibitor TargetMol T1996
    • Bio Activity:

      Angiogenesis TargetMol T1996
      Defactinib(VS-6063; PF-04554878) is a potent FAK phosphorylation inhibitor; overcomes YB-1?mediated paclitaxel; resistance by an AKT-dependent pathway.; IC50 value:; Target: FAK inhibitor; VS-6063 inhibited FAK phosphorylation at the Tyr397 site in a time- and dose-dependent manner. MedChem Express HY-12289
      Defactinib(VS-6063; PF-04554878) is a potent FAK phosphorylation inhibitor; overcomes YB-1?mediated paclitaxelresistance by an AKT-dependent pathway.;IC50 value:;Target: FAK inhibitorVS-6063 inhibited FAK phosphorylation at the Tyr397 site in a time- and dose-dependent manner. The combination of VS-6063 and paclitaxel markedly decreased proliferation and increased apoptosis, which resulted in 92.7% to 97.9% reductions in tumor weight. RPPA data showed that VS-6063 reduced levels of AKT and YB-1 in taxane-resistant cell lines. FAK inhibition enhanced chemosensitivity in taxane-resistant cells by decreasing YB-1 phosphorylation and subsequently CD44 in an AKT-dependent manner. MedChem Express HY-12289
      Defactinib(VS-6063; PF-04554878) is a potent FAK phosphorylation inhibitor; overcomes YB-1–mediated paclitaxel MedChem Express
      FAK MedChem Express HY-12289
      FAK TargetMol T1996
      Protein Tyrosine Kinase/RTK MedChem Express HY-12289
      Protein Tyrosine Kinase/RTK; MedChem Express HY-12289

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.5±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.616
Molar Refractivity: 119.3±0.4 cm3
#H bond acceptors: 11
#H bond donors: 3
#Freely Rotating Bonds: 9
#Rule of 5 Violations: 2
ACD/LogP: -0.74
ACD/LogD (pH 5.5): 1.27
ACD/BCF (pH 5.5): 5.47
ACD/KOC (pH 5.5): 117.27
ACD/LogD (pH 7.4): 1.28
ACD/BCF (pH 7.4): 5.49
ACD/KOC (pH 7.4): 117.72
Polar Surface Area: 150 Å2
Polarizability: 47.3±0.5 10-24cm3
Surface Tension: 63.5±3.0 dyne/cm
Molar Volume: 341.4±3.0 cm3

Click to predict properties on the Chemicalize site






Advertisement